Trial Profile
A Multicenter, Open Label, Single-arm Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 Apr 2015
Price :
$35
*
At a glance
- Drugs Dexrazoxane (Primary)
- Indications Extravasation
- Focus Adverse reactions
- Sponsors Kissei Pharmaceutical
- 17 Apr 2015 New trial record